Earnings History Data for DMK Pharmaceuticals Corporation (DMK) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
DMK Pharmaceuticals Corporation
DMK Pharmaceuticals is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. DMK Pharmaceuticals, formerly known as Adamis Pharmaceuticals Corporation, is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2023 | PM | DMK | DMK Pharmaceuticals Corporation | 4.59 | -0.25 | 0.00 | -2.10 | DMK Pharmaceuticals GAAP EPS of -$0.20 [11/14/2023 7:45 AM] |
0.5126 | -0.02 (-3.47%) |
0.51 | -0.03 (-4.80%) |
0.45 - 21.70 | 84,825 | 120,000 | 33,176 | ||